There we go. Nice big healthy buy to kick things off. And why wouldn't you at these levels. Any positive outcome from the arbitration with a payout exceeding current annual expenditure ($8mil) plus the daptomycin license back in our hands will see at least a 100% increase in share price (or it should) IMO. I think investors at this level will be ecstatic if that payout is multiples of annual expenditure.
Mylan arbitration
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $12.67M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $1.2K | 316K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 47 | 70046883 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 38947842 | 19 |
View Market Depth
| Last trade - 10.12am 21/05/2024 (20 minute delay) ? |
| AVE (ASX) Chart |